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Abstract: Parkinson’s disease (PD) alters the motor performance of affected individuals. 
The dopaminergic denervation of the striatum, due to substantia nigra neuronal loss, 
compromises the speed, the automatism and smoothness of movements of PD patients. The 
development of a reliable tool for long-term monitoring of PD symptoms would allow the 
accurate assessment of the clinical status during the different PD stages and the evaluation 
of motor complications. Furthermore, it would be very useful both for routine clinical care 
as well as for testing novel therapies. Within this context we have validated the feasibility 
of using a Body Network Area (BAN) of wireless accelerometers to perform continuous at 
home gait monitoring of PD patients. The analysis addresses the assessment of the system 
performance working in real environments. 
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1. Introduction 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s 
disease and it is expected to impose an increasing social and economic burden on society in the coming 
decades. The prevalence of PD in industrialized countries is generally estimated at 0.3% of the entire 
population and about 1% in people over 60 years of age. Reported standardized incidence rates of PD are 
8–18 per 100,000 person-years. Onset of PD is rare before age 50 and a sharp increase of the incidence is 
seen after age 60 [1]. About 20% of people over the age of 80 have Parkinsonism-associated gait 
disturbances. The major motor disturbances in PD are bradykinesia (i.e., slowness of movement), 
hypokinesia (decreased movement amplitude), resting tremors, rigidity, and postural instability [2]. 
These major motor features of PD are associated with, and are largely a result of, the loss of 
dopaminergic innervation of the basal ganglia. Although a genetic predisposition has been identified in a 
subset of patients with PD, several other risk factors for PD have been recognized [3–5]. The cause and 
etiology of PD are still unknown [3–7]. In addition to multiple other effects, the impaired basal ganglia 
function in PD leads to alterations in gait and balance. These motor changes in PD often restrict 
functional independence and are a major cause of morbidity and mortality among these patients [8–11]. 
PD is typically characterized by severe, unpredictable and abrupt changes in the patient motor 
performance whereby OFF periods, characterized by a drug’s effectiveness wearing off, alternate with 
ON periods, during which medication effectively improves movement. 
These motion changes can be detected by studying the variation of the signals recorded by 
accelerometers attached in the limbs and belt of the patients. Furthermore, the analysis of the most 
significant changes in these signals makes possible to build an individualized profile of the disease, 
personalize the medication intakes and improve the response of the patient to the treatment [12]. 
Within this work we analyze the feasibility of using a Body Network Area (BAN) of wireless 
accelerometers to perform a continuous gait monitoring of PD patients at their homes. The 
development of a reliable tool for the continuous monitoring of gait in PD patients would provide 
several benefits for PD patients and for the general practice: (1) in the long-term, a better 
understanding of the disease evolution on every patient and an indicative of the PD progression; and 
(2) in the short-term, the detection of abrupt changes in the gait measures on a daily basis could lead to 
the identification of wearing off phases. In both cases, the identification of such events (PD progression 
and/or wearing off phases) will contribute to enrich the clinical decision making process with more and 
more reliable data. 
1.1. Gait Disturbances in Parkinson’s Disease: Classification 
The gait disturbances in PD may be divided into two types [3]: (1) continuous, mainly characterised 
by a reduction of gait speed [13] and (2) episodic [14,15]. The episodic gait disturbances occur 
occasionally and intermittently and appear randomly. The episodic gait disturbances include 
festination, gait initiation hesitation, and freezing of gait [9,16–18]. Freezing of gait is an 
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incapacitating phenomenon that is experienced mainly by patients with advanced PD [9,19–21]. The 
continuous changes refer to alterations in the walking pattern (temporal and spatial kinematic 
parameters). Both types of disturbances are due to dysfunction of the basal ganglia, although the 
mechanisms for such disturbances are independent and they are responsible for the increase in the 
incidence of falls in PD patients [9]. Falls are one of the most significant consequences of a disturbed 
gait in PD [9,17,22,23]. As the disease progresses, gait impairment and falls become increasingly 
important and develop into one of the main complaints among PD patients and caregivers. The most 
relevant changes (temporal and spatial) affected by PD are apparent only when gait is evaluated 
quantitatively with gait analysis systems. Increased left-right gait asymmetry and diminished left-right 
bilateral coordination are changes affected by the disease [22,23]. Another gait feature in PD patients 
seems to be the inability to generate a consistent and steady gait rhythm, resulting in an increase in 
higher stride-to-stride variability [24–26]. An increase of gait variability can be detected throughout the 
disease even in early the stages of the disease when patients have not started taking anti-Parkinsonian 
medications [25]. The magnitude of the variability is enhanced by disease severity. It has been shown the 
relationship between gait variability, fall history and other Parkinsonian features [26–29]. An effect of 
levodopa administration has been described on gait variability and fall frequency in PD patients [30]. In 
the OFF state, stride time variability was significantly larger among fallers compared to non-fallers [28]. 
Stride time variability decreased significantly in response to levodopa in both groups (fallers and  
non-fallers) [30]. However, in the ON state, stride time variability remained significantly higher in the 
fallers than non-fallers. The locomotor control system that regulates gait variability and gait phases 
timing is impaired in PD patients with a history of falls [28]. On the other hand, no significant 
correlation has been described between stride-to-stride variability with other motor features such as 
tremor, rigidity, or bradykinesia in the OFF state [28]. In addition, levodopa decreases stride-to-stride 
variability in non-fallers, suggesting that dopaminergic networks regulate the control of gait variability 
and timing suggesting the possibility of damaged and exaggerated impairment of ―internal clock‖ 
function in PD fallers [28]. In the ON state, when the motor performance is optimal, the PD fallers 
showed also a further increased control of stride-to-stride variability. The authors of [28] suggest the 
possibility of damaged and exaggerated impairment of ―internal clock‖ function in PD fallers. In 
addition Parkinson’s disease patients have shown impaired visual sampling during gait through 
complex environments. They had fewer early preparatory saccades recorded than controls preceding 
turns and under dual-task conditions made less frequent saccades than controls [31]. 
1.2. Parkinson’s Disease Monitoring 
The evolution of wearable sensors and systems during the last decade, introducing new capabilities 
and extending the functions of existing ones, has led to the development of a wide range of tools and 
services for the patient home monitoring. Neurodegenerative disorders, such as Parkinson’s Disease, 
have also benefited from these advances [32]. The development of a reliable quantitative tool suitable 
for continuous monitoring able to evaluate the motor performance evolution, as well as sudden 
changes from ON-OFF state, would be an important step forward both for routine clinical care as well 
as for trials of novel therapies, i.e., drugs or devices. Gait performance deterioration is one of the major 
symptoms of PD and it is composed of different elements, i.e. freezing of gait, gait, bradykinesia and 
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postural instability [2]. Due to such complexity, gait disorders reflect important pathological 
mechanisms underlying PD and therefore they are a good model for a quantitative estimation. Several 
works have addressed these issues using wearable and wireless technologies. Tien et al. [33] have 
developed a wireless inertial sensor system to characterize gait abnormalities in PD by analyzing 
physical features such as pitch, roll, and yaw rotations of the foot during walking. Then, the Principal 
Component Analysis (PCA) technique was used to select the best features, and finally a classification 
model was built using a Support Vector Machine (SVM). Results have demonstrated the ability of 
successfully detect the presence of PD based on physical features of gait. In [34] researchers have used 
a miniaturized triaxial accelerometer-based system for the detection of gait and postures concluding 
that a triaxial monitor system is a practical and valuable tool for objective, continuous evaluation of 
walking and postures in patients with mild to moderate PD. Wearable sensors have also been 
integrated with web-based applications [35–38] enabling home monitoring of patients with (PD) using 
wearable sensors. This web application offers three different options: a resource-aware data collection 
engine that relies upon wearable sensors, web services for live streaming and storage of sensor data, 
and a web-based graphical user interface client with video conferencing capability. Reference [39] has 
suggested a system for the early automatic recognition of health problems that manifest themselves in 
a distinctive form of gait. The purpose of the system is to prolong the autonomous living of the elderly 
at home. The gait of the elderly user is captured using a motion-capture system, which consists of 
body-worn markers and wall-mounted sensors. A triaxial accelerometer was also used in the lower 
back to measure the variability (consistency and rhythmicity) of stepping [40] or to evaluate 
parameters derived from accelerometry data of gait in different neurological conditions with 
pathological gait impairment compared to healthy subjects [30]. Finally, in the work described in [41] 
subjects have performed standardized gait tests while wearing sport shoes equipped with inertial 
sensors (gyroscopes and accelerometers); signals were recorded wirelessly, features were extracted, 
and distinct subpopulations were classified, showing that it is possible to distinguish mild from severe 
gait impairment. 
2. Experimental Section 
2.1. Framework 
―A sophisticated multi-parametric system FOR the continuous effective assessment and Monitoring 
of motor status in Parkinson’s disease and other neurodegenerative diseases‖ (PERFORM) is a 
telematic platform for remote PD monitoring developed during the last years by a European 
Consortium of Small and Medium Enterprises (SMEs), large companies, Universities and research 
centers [12,42]. The current status of the project is a fully operative prototype which has been tested in 
three different hospitals across Europe: University of Navarra Medical School Hospital (Spain), the 
University of Ioannina Hospital (Greece) and the Nuovo Ospedale Civile S.Agostino-Estense of 
Modena (Italy). The PERFORM platform is composed by a set of four tri-axial accelerometers used to 
record the (3-axis) ccelerations of the movements at each patient limb and one accelerometer and 
gyroscope used to a record body accelerations and angular rate attached on the belt of the patient. 
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Sensors were placed in every limb and belt to detect and quantify a wide range of symptoms related to 
Parkinson’s disease, i.e., tremor, bradykinesia, dyskinesias, falls and freezing of gait (Figure 1). 
The four sensors in the limbs transmit data using the Zigbee protocol to a data logger device located 
on the belt of the patient, which receives and stores locally all the received signals. The sampling rate 
used was 62.5 Hz (16 milliseconds between each sample). This set of accelerometers and data logger 
were designed, developed and manufactured according to the requirements of the PERFORM project. 
In that sense, the sampling rate was fixed in 62.5 Hz due to the available technology, literature review 
and preliminary tests carried out within the first years of the project where such sensors were validated. 
It is important to highlight that the sensors do not need to be placed in a precise position since the 
system will work with the module of the 3-axis acceleration signal, not with a particular axis. The 
output of each axis is the acceleration in such direction and it ranges from −6 g to +6 g. It is possible to 
wear the devices without any help, nevertheless, some PD patients could require a caregiver’s help 
(depending on the patient mobility). The only requirement is to adjust the sensors as tightly as 
possible. These accelerometers do not provide any retransmission protocol; but all the transmitted 
samples incorporate a unique timestamp. Using this this timestamp it is possible to evaluate in the 
receptor if any packets was lost during the transmission. Apart from the wearable devices, each patient 
was provided with touch-screen PC at his/her home. The application installed in the PC carries out the 
signal processing tasks. At the end of the day, the logger is connected to the PC through a standard 
USB connection and all the data is automatically transferred to the computer. Once the raw data is 
downloaded from logger to the PC, it is automatically processed. This software is responsible for the 
identification and quantification of the patient. A customized graphical user interface (GUI) has been 
designed to allow the patients enter other useful information. The user could interact with it either with 
the mouse or with the touch screen modality. Using a touch-screen system offers interesting benefits in 
the PERFORM case [43]. Touching a visual display of choices requires little thinking and it is a form 
of direct manipulation easier to learn. Touch screens have more intuitive hand-eye coordination than 
mice or keyboards. Consequently, touch screens are the fastest pointing device. Besides, the GUI was 
tested on every phase of the pilots and redesigned according to the users’ feedback. The software 
allows the patients to insert the following information: 
 medication intake (type, dose and time) 
 meals (type of food, amount, time) 
 PDQ-39. An standard questionnaire for the evaluation of physical, emotional and psychosocial 
aspects of Quality of Life (QoL) in PD patients [44]. 
By definition, working on unsupervised environments implies an important number of challenging 
problems regarding the signals interpretation and signals quality validation [45]. Collecting this 
information is essential in order to create a context and to make the signal processing outcome useful 
in this sort of environments. In fact, motor behavior strongly depends on the assumption of the 
medication (in the usual patient’s dosage) and the metabolism of the drug is influenced by the diet 
(proteins or fats). 
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2.2. Participants 
Patients fulfilling the following criteria were eligible for the study: a diagnosis of Parkinson’s 
disease, aged between 40 and 70 years old, ambulatory, capable of complying with study requirements, 
receiving stable dopaminergic treatment, experiencing motor fluctuations and being supported by a 
responsible caregiver who can cooperate with patient and doctor. Participants suffering from dementia, 
hallucinations or any significant systemic disease were excluded from the study. Table 1 shows the 
assessment of bradykinesia, gait and limbs’ rigidity according to the Unified Parkinson’s Disease 
Rating Scale (UPDRS) [46], this evaluation was done by a clinician on the first day of the test. 
Before taking part to the study, patients were provided with a participant information sheet 
describing the study in their own language as well as an oral explanation of the research expressed in 
terms that would have the best chance of being understood. The experimental nature of this study, its 
inherent risks and drawbacks, and its chance of improving the treatment of PD were discussed. Then 
clinician obtained informed consent and gave a letter with a synopsis of Perform Protocol for family 
doctor to inform him about main issues of the study. 
Figure 1. Sensors and data logger used for data collection and their position on the body. 
 
2.3. Data Collection 
The PERFORM system was installed at patients’ homes. All patients were asked to wear the system 
in their homes and to move freely carrying out their daily activities. The patients were using the system 
between 5 and 7 days, running two sessions of 4 h each per day, Figure 2 shows an example of raw 
data collected during these sessions. During the first day, they and their caregivers received a training 
session about how to use properly the system and the sensors. Moreover, a printed manual was left at 
their homes and a telephone line was available for questions during the whole time as well. On the last 
day, both the patients and caregivers were interviewed to report problems or issues related with the use 
of the system. The guidelines to for the interview were extracted from the work of Knight et al. [47], 
who suggested a methodology to assess the comfort of wearable computers. 
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2.4. Data Analysis 
People suffering from PD are unable to move fluently and that modifies the walking pattern 
generating a more complex and entropic signal. This approach constitutes an important tool for the 
detection of a PD walking pattern. We can see that x-axis (corresponding with the cranio-caudal axis) 
and z-axis (corresponding with the anterio-posterior axis) contain most of the information related with 
the walking movement. During forward movement and as consequence of each step the, acceleration 
along the z-axis increases and decreases following the gait cycle. 
Figure 2. This figure shows raw data coming from the four accelerometers in the limbs. 
The module of the 3-axis sensors is plotted to show how each of these signals change when 
the subject perform different daily tasks. Signals RW (right wrist) and LW (left wrist) 
show the acceleration in the wrists and RL (right leg) and LL (left leg) acceleration in the 
legs. Panel (a) shows the subject opening a door with her left hand and the arrow links this 
moment with the raw data signal. Panel (b) shows the subject moving her right hand to 
drink water and the corresponding raw signal. Panel (c) shows a moment where the patient 
was walking. The arrows relate the tasks with the response in the signals. The PERFORM 
system has its own activity recognizer module which is based on analysis of these signals 
as explained in [48]. 
 
Two different types of analysis are performed; the first one using intrinsic features of the signal, 
specifically entropy, which by definition is an excellent feature to measure complexity. Entropy is the 
measure of the uncertainty or unpredictability associated to a specific variable, or in other words, it is a 
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measure of the disorder. Former works [49–51] have shown how to use the technique ―Sample 
Entropy‖ to calculate the variability and complexity of gait in PD disease. Sample entropy quantifies 
the regularity of a time series. It reflects the conditional probability that two series of ―m‖ consecutive 
data points which are similar to each other will remain similar when one more consecutive point is 
included [52]. Two data series are considered similar if the value of a specific measure of distance is 
less than a parameter ―r‖. 
Table 1. Details of the patients enrolled in the feasibility study. Table shows the sex, age 
and clinical evaluation of the patients during their ON and OFF states according to the 
UPDRS scale [46]. 
Id Sex (Age) Status Gait Bradykinesia 
Left leg 
rigidity 
Right leg 
rigidity 
Left wrist 
rigidity 
Right wrist 
rigidity 
1 F (71) 
OFF 0 1 1 1 1 1 
ON 0 1 1 0 1 0 
2 M (68) 
OFF 0 0-1 1–2 0–1 1 0–1 
ON 0 0 0 0 0 0 
3 M (63) 
OFF 0 0 1 1 1 1 
ON 0 0 0 0–1 0 1 
4 F (67) 
OFF 3 2 2 2 1 2 
ON 1 1 1 1 1 1 
5 M (63) 
OFF 0 0 0 1 0 2 
ON 0 0 0 1 0 2 
6 M (68) 
OFF 0 3 0 0 1 1 
ON 0 1 1 2 1 1 
7 M (76) 
OFF 0 1 1 0 0 1–2 
ON 0 0 1 0 1 2 
8 M (52) 
OFF 4 3 4 4 4 4 
ON 1 1 1 1 1 1 
9 F (56) 
OFF 2 3 3 2 3 2 
ON 1 0 1 0 1 0 
10 M (58) 
OFF 2 3 3 3 3 3 
ON 1 1 1 1 1 1 
11 F (79) 
OFF 0 2 1 1 1 1 
ON 0 0 0 0 0 0 
On the other hand, ―secondary measures‖ or classic gait parameters i.e., step frequency, velocity, 
stride length are also evaluated. To estimate the stride length we use the ―inverted pendulum model of 
human walking‖ [53], with an average error in the step frequency characterization of 1.88% [49]. The 
limitation of these features in an unsupervised environment is that they can change not necessarily 
because of a worsening on the patient status but for the willingness of the patient, i.e., the patient at 
home can walk slowly or run depending on the situation. For this reason we include extra measures 
able to estimate the worsening of the walking pattern independently of the patient activities, the 
measure of the entropy of the accelerometer signal has been proved to be one the best indicators to 
discriminate between a ―healthy‖ pattern and a walking pattern coming from a PD patient [49]. 
Actually, this result is completely aligned with the discussion about the Figures 3 and 4. 
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In addition, the analysis of the movement pattern in healthy subjects helps to establish a comparison 
with the output of the PD’s patient recording. Figures 3 and 4 show the acceleration in the belt sensor 
for each axis in a healthy subject and in a PD patient and it is possible to see the degradation of the gait 
pattern in a PD patient. Finally, it is necessary to point out that a segmentation module was developed 
within PERFORM in order to analyze when the patient was actually walking [48] and run the gait 
characterization algorithms only at that times. This work has proved that even two accelerometers are 
enough to classify walking activities with higher than 99% accuracy. 
Figure 3. Signals from the belt sensor in a healthy subject. From top to bottom the figure 
shows the x-axis, y-axis and z-axis. Values on the horizontal axis are samples and vertical 
axis is the normalized output of the accelerometers [49], the acceleration value of the 
sensors range from −6 g to +6 g, the vertical axis of the figure shows the values normalized 
between 0 and 1 by subtracting the minimum (−6 g) and dividing by the range (12 g). 
 
3. Results and Discussion 
Working in an unsupervised and wireless environment achieving a low data loss rate became 
essential. In the last release of the PERFORM platform, the four accelerometers in the limbs work 
simultaneously and transmit data in separate time slots avoiding most of the packet loss. Nevertheless 
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sometimes there could be something between the sensor and the receiver, i.e., when patient is walking 
the body is between the sensor and the receiver and that could generate some packet loss. 
Figure 4. Signals from the belt sensor in a PD patient. From top to bottom the figure shows 
the x-axis, y-axis and z-axis. Values on the horizontal axis are samples and vertical axis is 
directly is the normalized output of the accelerometers [49], the acceleration value of the 
sensors range from −6 g to +6 g, the vertical axis of the figure shows the values normalized 
between 0 and 1 by subtracting the minimum (−6 g) and dividing by the range (12 g). 
 
Table 2 shows the average data loss and standard deviation, the average length of data loss burst and 
standard deviation and the most frequent length of data loss burst. The average data loss satisfied that in 
all cases more than 95% of the data is successfully transmitted. Nevertheless, analyzing the average burst 
length and the standard deviation of these values we found burst of up to 143.04 ± 240.10 ms, a burst of 
these characteristics in the middle of the transmission would compromise seriously the performance 
and accuracy of the system. Nevertheless, adding the most frequent burst length as an extra measure 
and observing the raw data we can easily identify that 64 ms is the most common burst in all the cases, 
and moreover, the longest bursts are always at the beginning of the session, i.e., during the startup 
process. That means that waiting for all the sensors to be properly connected before start computing 
the gait features will remove the longest burst errors. Then, we will still keep sporadic disconnections 
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of 64 ms (the minimum time for the data logger to reconnect with the accelerometer) which will still 
guarantee a much more acceptable average data loss. 
Table 2. Data loss measures for the accelerometer network working on a real environment. 
Id Data loss (%) Average burst error length (ms) Most frequent burst error length (ms) 
1 0.95 ± 0.77% 111.55 ± 532.89 64 
2 0.97 ± 0.55% 92.07 ± 242.97 64 
3 2.02 ± 0.78% 104.22 ± 531.12 64 
4 1.14 ± 1.12% 101.25 ± 532.89 64 
5 1.51 ± 1.17% 114.85 ± 529.04 64 
6 0.32 ± 0.37% 143.04 ± 240.10 64 
7 1.83 ± 1.04% 139.44 ± 542.15 64 
8 1.25 ± 1.26% 123.64 ± 242.97 64 
9 1.31 ± 1.02% 174.26 ± 527.90 64 
10 1.27 ± 1.07% 115.10 ± 542.15 64 
11 1.84 ± 1.11% 106.55 ± 542.59 64 
The interview with patients and caregivers after using the system for a week also resulted in 
interesting comments. The majority of the patients, two thirds, did not feel any discomfort/pain at most 
of their body parts. Only, one third of the patients felt extremely week discomfort/pain at their body. 
None of the patients had the perception of any kind of harm (e.g., headache, pain, itching, irritation, etc.) 
caused by the devices. The interview revealed some emotional and appearance issues of a group of 
patients (27.2%). These patients had some concerns about the impression they make to others when 
wearing the device. They would feel much more comfortable if the device was not visible or if they 
had to wear it only at home. All participants agreed that the provided solution did not obstruct them in 
everyday activities neither limit their activities in an effective way. The only concern expressed by a 
significant number of patients was regarding the proper attachment of the current appliance. 
4. Conclusions and Outlook 
Home Health Monitoring is more than using wearable sensors at patients’ home, especially, talking 
about chronic disease management. It means to involve patients and caregivers in the healthcare path 
and shift their role from a passive position to an active position. And therefore, transform them in main 
actors of the healthcare process. The first and most obvious reason is that home telehealth systems 
need the participation and cooperation of patients and caregivers to work efficiently. In the PERFORM 
context the algorithms developed have achieved a good accuracy. Nevertheless, in order to achieve a 
good understanding of the disease in the patient and to build a profile of the patient, context 
information (i.e., food and medication intakes) is required. That means it is necessary to invest time 
and effort in the patient and caregiver training, to provide them with the adequate skills to use the 
system properly, as well as follow the best practices for GUI design. Moreover, it is important to make 
them aware of the importance of the self-assessment, not only for a reliable remote monitoring but also 
for improvement of their disease management. It is important to keep in mind that different subjects 
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perform different walking patterns and even the same subject will walk differently depending on the 
situation. The lack of contextual information makes working in unsupervised environments a very 
challenging task. Parameters related to the walking analysis are not fully representative (speed and 
stride length are features which need to be in a context, we need to be aware of the fact that sometimes 
the patient could walk slower than usual because he wants to, e.g., because he is relaxed at home) and 
the use of alternative measures like entropy are a better choice. As a general recommendation the 
involvement of an active patient becomes crucial in order to contextualize as much as possible the raw 
biomedical signals. From this experience, it is also important to remark the importance of working in 
more accurate activity recognizers, as well as affective recognizers able to segment the activities and 
moods of the subject during their daily life. 
Studying the walking pattern on PD patients is a promising tool in order to develop a continuous 
monitoring system able to identify the different phases of the disease within the day (OFF-ON). This 
system could easily alert the professionals when the patient faces an OFF phase, measuring the degradation 
of the walking pattern, indicating that a schedule change in the medication treatment is needed. 
Contextual data is crucial in order to be able to interpret and contextualize the patient gait 
performance. The use of a patient diary provides excellent information to correlate with the movement 
assessment, and the new generation of smartphones is a convenient platform to integrate the patient 
diary and the data collection coming from the limb sensors. Likely the future of this technology will 
move to the use of these platforms. 
Acknowledgments 
This work is partially funded by the European Commission under the PERFORM project (7th 
Framework Programme), grant agreement: 215952. The authors thank the PERFORM consortium for their 
contribution to this work, especially the University of Navarra Medical School Hospital (Pamplona, Spain) 
and the University of Ioannina (Greece). The authors would like also to thank Ana Gonzalez Marcos,  
Jose Antonio Martin Pereda and Francisco del Pozo for their support. Research by Jorge Cancela has 
been partly supported by a PICATA predoctoral fellowship of the Moncloa Campus of International 
Excellence (UCM-UPM). 
Author Contributions 
(1) Jorge Cancela and Matteo Pastorino make substantial contributions in the plan and design of the 
work, in the data analysis, and in the literature search and paper writing; (2) Maria T. Arredondo makes 
substantial contributions in the data analysis and interpretation, in the concept definition and in the critical 
revision of the article; (3) Konstantina S. Nikita makes a substantial contribution to this work with a critical 
revision of the article and (4) Federico Villagra and Maria A. Pastor make substantial contributions in the 
data collection process, in the definition of the clinical requirements and writing the clinical section of  
the manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
Sensors 2014, 14 4630 
 
 
References 
1. De Lau, L.M.L.; Breteler, M.M.B. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006, 5, 
525–535. 
2. Tugwell, C. Parkinson’s Disease in Focus; Pharmaceutical Press: London, UK, 2008. 
3. Gan-Or, Z.; Giladi, N.; Rozovski, U.; Shifrin, C.; Rosner, S.; Gurevich, T.; Bar-Shira, A.;  
Orr-Urtreger, A. Genotype-phenotype correlations between GBA mutations and Parkinson disease 
risk and onset. Neurology 2008, 70, 2277–2283. 
4. Orr-Urtreger, A.; Shifrin, C.; Rozovski, U.; Rosner, S.; Bercovich, D.; Gurevich, T.; Yagev-More, H.; 
Bar-Shira, A.; Giladi, N. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson 
disease: Is there a gender effect? Neurology 2007, 69, 1595–1602. 
5. Kandinov, B.; Giladi, N.; Korczyn, A.D. Smoking and tea consumption delay onset of 
Parkinson’s disease. Park. Relat. Disord. 2009, 15, 41–46. 
6. Shastry, B.S. Parkinson disease: Etiology, pathogenesis and future of gene therapy. Neurosci. Res. 
2001, 41, 5–12. 
7. Wider, C.; Wszolek, Z.K. Etiology and pathophysiology of frontotemporal dementia, Parkinson 
disease and Alzheimer disease: Lessons from genetic studies. Neurodegener. Dis. 2008, 5, 122–125. 
8. Morris, M.E.; Iansek, R.; Matyas, T.A.; Summers, J.J. The pathogenesis of gait hypokinesia in 
Parkinson’s disease. Brain 1994, 117, 1169–1181. 
9. Bloem, B.R.; Hausdorff, J.M.; Visser, J.E.; Giladi, N. Falls and freezing of gait in Parkinson’s 
disease: A review of two interconnected, episodic phenomena. Mov. Disord. 2004, 19, 871–884. 
10. Balash, Y.; Peretz, C.; Leibovich, G.; Herman, T.; Hausdorff, J.M.; Giladi, N. Falls in outpatients 
with Parkinson’s disease: Frequency, impact and identifying factors. J. Neurol. 2004, 251,  
1310–1315. 
11. Pickering, R.M.; Grimbergen, Y.A.M.; Rigney, U.; Ashburn, A.; Mazibrada, G.; Wood, B.; Gray, P.; 
Kerr, G.; Bloem, B.R. A meta-analysis of six prospective studies of falling in Parkinson’s disease. 
Mov. Disord. 2007, 22, 1892–1900. 
12. Cancela, J.; Pastorino, M.; Arredondo, M.T.; Hurtado, O. A telehealth system for Parkinson’s 
disease remote monitoring. The PERFORM approach. In Proceedings of the Annual International 
Conference of the IEEE Engineering in Medicine and Biology Society, Osaka, Japan, 3–7 July 
2013; pp. 7492–7495. 
13. Stolze, H.; Kuhtz-Buschbeck, J.P.; Drücke, H.; Jöhnk, K.; Illert, M.; Deuschl, G. Comparative 
analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease. J. Neurol. 
Neurosurg. Psychiatry 2001, 70, 289–297. 
14. Giladi, N.; Hausdorff, J.M.; Balash, Y. Episodic and continuous gait disturbances in Parkinson’s 
disease. In Scientific Basis for the Treatment of Parkinson’s Disease; Nestor Galvez-Jimenez, N., Ed.; 
Francis, CRC Press: London, UK, 2005; pp. 321–332. 
15. Giladi, N.; Balash, J. Paroxysmal locomotion gait disturbances in Parkinson’s disease.  
Neurol. Neurochir. Pol. 2001, 35, 57–63. 
16. Bloem, B.R.; Grimbergen, Y.A.; Cramer, M.; Willemsen, M.; Zwinderman, A.H. Prospective 
assessment of falls in Parkinson’s disease. J. Neurol. 2001, 248, 950–958. 
Sensors 2014, 14 4631 
 
 
17. Gray, P.; Hildebrand, K. Fall risk factors in Parkinson’s disease. J. Neurosci. Nurs. J. Am. Assoc. 
Neurosci. Nurses 2000, 32, 222–228. 
18. Nutt, J.G.; Bloem, B.R.; Giladi, N.; Hallett, M.; Horak, F.B.; Nieuwboer, A. Freezing of gait: 
Moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011, 10, 734–744. 
19. Giladi, N.; McDermott, M.P.; Fahn, S.; Przedborski, S.; Jankovic, J.; Stern, M.; Tanner, C. 
Freezing of gait in Parkinson’s disease. J. Neurol. 2001, 253, 27–32. 
20. Giladi, N.; Treves, T.A.; Simon, E.S.; Shabtai, H.; Orlov, Y.; Kandinov, B.; Paleacu, D.;  
Korczyn, A.D. Freezing of gait in patients with advanced Parkinson’s disease. J. Neural Transm. 
2000, 108, 53–61. 
21. Giladi, N.; McDermott, M.P.; Fahn, S.; Przedborski, S.; Jankovic, J.; Stern, M.; Tanner, C. 
Freezing of gait in PD: Prospective assessment in the DATATOP cohort. Neurology 2001, 56, 
1712–1721. 
22. Ashburn, A.; Stack, E.; Pickering, R.M.; Ward, C.D. Predicting fallers in a community-based 
sample of people with Parkinson’s disease. Gerontology 2001, 47, 277–281. 
23. Furukawa, Y.; Vigouroux, S.; Wong, H.; Guttman, M.; Rajput, A.H.; Ang, L.; Briand, M.;  
Kish, S.J.; Briand, Y. Is freezing of gait in Parkinson’s disease related to asymmetric motor 
function? Ann. Neurol. 2002, 57, 779–782. 
24. Blin, O.; Ferrandez, A.M.; Serratrice, G. Quantitative analysis of gait in Parkinson patients: 
Increased variability of stride length. J. Neurol. Sci. 1990, 98, 91–97. 
25. Baltadjieva, R.; Giladi, N.; Gruendlinger, L.; Peretz, C.; Hausdorff, J.M. Marked alterations in the 
gait timing and rhythmicity of patients with de novo Parkinson’s disease. Eur. J. Neurosci. 2006, 
24, 1815–1820. 
26. Hausdorff, J.M.; Cudkowicz, M.E.; Firtion, R.; Wei, J.Y.; Goldberger, A.L. Gait variability and 
basal ganglia disorders: Stride-to-stride variations of gait cycle timing in Parkinson’s disease and 
Huntington’s disease. Mov. Disord. 1998, 13, 428–437. 
27. Hausdorff, J.M.; Rios, D.A.; Edelberg, H.K. Gait variability and fall risk in community-living 
older adults: A 1-year prospective study. Arch. Phys. Med. Rehabil. 2001, 82, 1050–1056. 
28. Hausdorff, J.M. Gait dynamics in Parkinson’s disease: Common and distinct behavior  
among stride length, gait variability, and fractal-like scaling. Chaos 2009, 19, 
doi:10.1063/1.3147408. 
29. Ebersbach, G.; Heijmenberg, M.; Kindermann, L.; Trottenberg, T.; Wissel, J.; Poewe, W. 
Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson’s 
disease: Evidence for impaired locomotor pattern generation in early Parkinson’s disease.  
Mov. Disord. 1999, 13, 336–338. 
30. Fazio, P.; Granieri, G.; Casetta, I.; Cesnik, E.; Mazzacane, S.; Caliandro, P.; Pedrielli, F.; 
Granieri, E. Gait measures with a triaxial accelerometer among patients with neurological 
impairment. Neurol. Sci. 2013, 34, 435–440. 
31. Galna, B.; Lord, S.; Daud, D.; Archibald, N.; Burn, D.; Rochester, L. Visual sampling during 
walking in people with Parkinson’s disease and the influence of environment and dual-task.  
Brain Res. 2012, 1473, 35–43. 
32. Bonato, P. Wearable sensors and systems. From enabling technology to clinical applications. 
IEEE Eng. Med. Biol. Mag. 2010, 29, 25–36. 
Sensors 2014, 14 4632 
 
 
33. Tien, I.; Glaser, S.D.; Aminoff, M.J. Characterization of gait abnormalities in Parkinson’s disease 
using a wireless inertial sensor system. In Proceedings of the Annual International Conference of 
the IEEE Engineering in Medicine and Biology Society, Buenos Aires, Argentina,  
31 August–4 September 2010; pp. 3353–3356. 
34. Dijkstra, B.; Kamsma, Y.P.; Zijlstra, W. Detection of gait and postures using a miniaturized 
triaxial accelerometer-based system: Accuracy in patients with mild to moderate Parkinson’s 
disease. Arch. Phys. Med. Rehabil. 2010, 91, 1272–1277. 
35. Chen, B.-R.; Patel, S.; Buckley, T.; Rednic, R.; McClure, D.J.; Shih, L.; Tarsy, D.; Welsh, M.; 
Bonato, P. A web-based system for home monitoring of patients with Parkinsons disease using 
wearable sensors. IEEE Trans. Biomed. Eng. 2011, 58, 831–836. 
36. Patel, S.; Chen, B.-R.; Buckley, T.; Rednic, R.; McClure, D.; Tarsy, D.; Shih, L.; Dy, J.;  
Welsh, M.; Bonato, P. Home monitoring of patients with Parkinson’s disease via wearable 
technology and a web-based application. In Proceedings of the Annual International Conference 
of the IEEE Engineering in Medicine and Biology Society, Buenos Aires, Argentina,  
31 August–4 September 2010; pp. 4411–4414. 
37. Roy, S.H.; Cole, B.T.; Gilmore, L.D.; de Luca, C.J.; Nawab, S.H. Resolving signal complexities 
for ambulatory monitoring of motor function in Parkinson’s disease. In Proceedings of the Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society, Boston, MA, 
USA, 30 August–3 September 2011; pp. 4832–4835. 
38. Patel, S.; Lorincz, K.; Hughes, R.; Huggins, N.; Growdon, J.; Standaert, D.; Akay, M.; Dy, J.; 
Welsh, M.; Bonato, P. Monitoring motor fluctuations in patients with Parkinson’s disease using 
wearable sensors. IEEE Trans. Inf. Technol. Biomed. 2009, 13, 864–873. 
39. Pogorelc, B.; Bosnić, Z.; Gams, M. Automatic recognition of gait-related health problems in the 
elderly using machine learning. Multimed. Tools Appl. 2011, 58, 333–354. 
40. Weiss, A.; Sharifi, S.; Plotnik, M.; van Vugt, J.P.P.; Giladi, N.; Hausdorff, J.M. Toward automated, 
at-home assessment of mobility among patients with Parkinson disease, using a body-worn 
accelerometer. Neurorehabil. Neural Repair 2011, 25, 810–818. 
41. Barth, J.; Klucken, J.; Kugler, P.; Kammerer, T.; Steidl, R.; Winkler, J.; Hornegger, J.; Eskofier, B. 
Biometric and mobile gait analysis for early diagnosis and therapy monitoring in Parkinson’s 
disease. In Proceedings of the Annual International Conference of the IEEE Engineering in 
Medicine and Biology Society, Boston, MA, USA, 30 August–3 September 2011; pp. 868–871. 
42. PERFORM Project Official Website. Available online: http://www.perform-project.eu/ (accessed 
on 4 March 2014). 
43. Caprani, N.; O’Connor, N.E.; Gurrin, C. Touch Screens for the Older User. In Assistive 
Technologies; Auat Cheein, F., Ed.; InTech: Rijeka, Croatia, 2012. 
44. Martínez-Martín, P.; Frades Payo, B. Quality of life in Parkinson’s disease: Validation study of 
the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J. Neurol. 
1998, 245, S34–S38. 
45. Lovell, N.H.; Redmond, S.J.; Basilakis, J.; Shany, T.; Celler, B.G. Telehealth technologies for 
managing chronic disease—Experiences from Australia and the UK. In Proceedings of the 2010 
Annual International Conference of the IEEE Engineering in Medicine and Biology Society 
(EMBC), Buenos Aires, Argentina, 31 August–4 September 2010; pp. 5267–5269. 
Sensors 2014, 14 4633 
 
 
46. Goetz, C.; Poewe, W.; Rascol, O.; Sampaio, C. The unified Parkinson’s disease rating scale 
(UPDRS): Status and recommendations. Society 2003, 18, 738–750. 
47. Knight, J.F.; Baber, C. Assessing the physical loading of wearable computers. Appl. Ergon. 2007, 
38, 237–247. 
48. Maziewski, P.; Kupryjanow, A.; Kaszuba, K.; Czyzewski, A. Accelerometer signal pre-processing 
influence on human activity recognition. In Proceedings of the IEEE Signal Processing 
Algorithms, Architectures, Arrangements, and Applications Conference, Poznan, Poland,  
24–26 September 2009; pp. 95–99. 
49. Cancela, J.; Pastorino, M.; Arredondo, M.T.; Pansera, M.; Pastor-Sanz, L.; Villagra, F.;  
Pastor, M.A.; Gonzalez, A.P. Gait assessment in Parkinson’s disease patients through a network 
of wearable accelerometers in unsupervised environments. In Proceedings of the Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society, Boston, MA, 
USA, 30 August–3 September 2011; pp. 2233–2236. 
50. Pansera, M.; Estrada, J.; Cancela, J.; Pastor, L.; Arredondo, M.T. Assessment of gait complexity 
in Parkinson’s disease through a network of wireless wearable sensors. In Proceedings of  
the 3rd European Conference on Ambient Intelligence (AmI09), Salzburg, Austria, 18–21 
November 2009. 
51. Pansera, M.; Estrada, J.J.; Pastor, L.; Cancela, J.; Greenlaw, R.; Arredondo, M.T.  
Multi-parametric system for the continuous assessment and monitoring of motor status in 
Parkinson’s disease: An entropy-based gait comparison. In Proceedings of the Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society, Minneapolis, 
MN, USA, 3–6 September 2009; pp. 1242–1245. 
52.  Richman, J.S.; Moorman, J.R. Physiological time-series analysis using approximate entropy and 
sample entropy. Am. J. Physiol. Circ. Physiol. 2000, 278, H2039–H2049. 
53. Alvarez, D.; Gonzalez, R.C.; Lopez, A.; Alvarez, J.C. Comparison of step length estimators from 
weareable accelerometer devices. In Proceedings of the Annual International Conference of the 
IEEE Engineering in Medicine and Biology Society, New York, NY, USA, 31 August–3 September 
2006; pp. 5964–5967. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
